The BMJ’s data sharing policy now applies to all clinical trials
The BMJ requires sharing of individual patient data for all clinical trials.
This means that trials will be considered for publication only if the authors agree to make the relevant anonymised patient level data available on reasonable request.
The BMJ is the first general medical journal to require data sharing for all trials, extending its initial policy on sharing data for trials of drugs or devices, which took effect in January 2013, says Elizabeth Loder, The BMJ’s acting head of research.
…
Today’s announcement follows initiatives by the US Institute of Medicine (IOM), the World Health Organization (WHO), and the Nordic Trial Alliance, to encourage data transparency.
…